| Primary |
| Carcinoid Tumour |
18.7% |
| Acromegaly |
14.7% |
| Carcinoid Syndrome |
14.7% |
| Metastatic Carcinoid Tumour |
10.7% |
| Neuroendocrine Carcinoma |
6.7% |
| Neuroendocrine Tumour |
6.7% |
| Diarrhoea |
5.3% |
| Pain |
4.0% |
| Pancreatitis Chronic |
2.7% |
| Small Intestine Carcinoma |
2.7% |
| Asthenia |
1.3% |
| Bladder Spasm |
1.3% |
| Blood Cholesterol |
1.3% |
| Blood Pressure |
1.3% |
| Bone Disorder |
1.3% |
| Carcinoid Tumour Of The Pancreas |
1.3% |
| Cardiac Disorder |
1.3% |
| Deep Vein Thrombosis |
1.3% |
| Depression |
1.3% |
| Diabetes Mellitus |
1.3% |
|
| Death |
30.0% |
| Neoplasm Malignant |
6.7% |
| Vomiting |
6.7% |
| Malignant Neoplasm Progression |
5.0% |
| Neoplasm |
5.0% |
| Weight Decreased |
5.0% |
| Carcinoid Tumour |
3.3% |
| Diarrhoea |
3.3% |
| Disease Progression |
3.3% |
| General Physical Health Deterioration |
3.3% |
| Local Swelling |
3.3% |
| Metastases To Liver |
3.3% |
| Neoplasm Progression |
3.3% |
| Pain |
3.3% |
| Pancreatic Carcinoma |
3.3% |
| Pollakiuria |
3.3% |
| Stress |
3.3% |
| Blood Growth Hormone Increased |
1.7% |
| Blood Triglycerides Increased |
1.7% |
| Carcinoid Syndrome |
1.7% |
|
| Secondary |
| Carcinoid Tumour |
48.8% |
| Carcinoid Syndrome |
7.0% |
| Blood Pressure |
5.8% |
| Depression |
5.8% |
| Diabetes Mellitus |
5.8% |
| Pain In Extremity |
5.8% |
| Prostate Cancer |
5.8% |
| Acromegaly |
2.3% |
| Diarrhoea |
2.3% |
| Metastatic Carcinoid Tumour |
2.3% |
| Bladder Spasm |
1.2% |
| Blood Cholesterol |
1.2% |
| Off Label Use |
1.2% |
| Pain |
1.2% |
| Pancreatic Neuroendocrine Tumour |
1.2% |
| Pancreatitis Chronic |
1.2% |
| Sleep Disorder |
1.2% |
|
| White Blood Cell Count Increased |
60.7% |
| Underdose |
8.2% |
| Glossodynia |
3.3% |
| Malignant Neoplasm Progression |
3.3% |
| Needle Issue |
3.3% |
| Neoplasm |
3.3% |
| Weight Decreased |
3.3% |
| Metastases To Liver |
1.6% |
| Movement Disorder |
1.6% |
| Pain In Extremity |
1.6% |
| Pancreatic Carcinoma |
1.6% |
| Paraesthesia |
1.6% |
| Thrombosis |
1.6% |
| Urinary Tract Infection |
1.6% |
| Ventricular Extrasystoles |
1.6% |
| Vomiting |
1.6% |
|
| Concomitant |
| Acromegaly |
66.7% |
| Gigantism |
33.3% |
|
| Injection Site Bruising |
100.0% |
|
